Joseph Arboleda-Velasquez
@drjoearboleda
Assistant Professor at Harvard Medical School, working on resistance to dementia treatments
ID: 887048143791169536
https://josepharboleda.wixsite.com/profile 17-07-2017 20:35:32
185 Tweet
216 Followers
191 Following
25 years ago, Joseph Arboleda-Velasquez faced enormous publishing challenges. That's why ScienceBank is here. Here's our story. 👇🏽
Call for Papers! 📢 We are excited to announce the launch of our new domain in #Pharmacology under the expert leadership of Dr. Taruna Ikrar, a renowned figure in the field. This domain features a #community #edition led by Dr. Mahmoud Ramadan. 👇 #academia
Having 1 copy of a rare APO allele (Christchurch) provides some protection, 4-5 year delay, from a familial autosomal dominant Alzheimer's disease nejm.org/doi/full/10.10… NEJM Yakeel T. Quiroz, PhD (she/her) Joseph Arboleda-Velasquez despite increased β-amyloid, but less Tau accumulation
On NPR : the protective role of reelin in #Alzheimers with Li-Huei Tsai and Joseph Arboleda-Velasquez npr.org/2024/07/24/nx-…
So, we were right 😆, Yakeel T. Quiroz, PhD (she/her), Joseph Arboleda-Velasquez, Grupo de Neurociencias de Antioquia #Reelin #Alzheimers
El equipo incluye a Dra. Carolina Ospina, Dra. Dorothee Schoemaker, Dra. Lina Marcela Velilla, Dra. Yesica Zuluaga, Dr. Francisco Lopera, Dr. Joseph Arboleda-Velasquez , y Dra. Yakeel T. Quiroz, PhD (she/her).
Some of our communities include: - The NOTCH signaling community led by Joseph Arboleda-Velasquez, PhD - The Biomedical engineering community led by Martha Londoño Lopez, PhD - The Clinical ophthalmology community led by Dr. Lucia Buendia - The Pharmacology community led by Dr. Taruna Ikrar